SBIR/STTR Research Award
STTR Phase I: A Comprehensive Fluorescent Tool Set for Live Cell Imaging
Award amount
$149,997Program and phase
STTR · Phase IAward year
2007Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- MONTANA MOLECULAR LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KN3BF8Y27ES3
- Solicitation number
- NSF 06-598
- Topic code
- BT
Research abstract
This Small Business Technology Transfer (STTR) Phase I research project aims to develop new probes for targeting specific cellular compartments. This will be achieved by producing a library of green fluorescent-tagged proteins using a high throughput insertion strategy. Availability of these reagents would be of great value to cell biologists interested in cellular trafficking or other areas that would require the use of compartment-specific markers.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Fluorescent Biosensors for measuring the signaling kinetics of GPCR ligands that activate G12/13 pathways.
- Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
- An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
- An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
- A robust assay for detecting agonist bias in living cells.
Research funding history
14 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $6,693,315. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation